CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for KAKEN PHARMACEUTICAL CO., LTD. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

KAKEN PHARMACEUTICAL CO., LTD.
20F, Bunkyo Green Court Center Office
2-28-8, Honkomagome
Phone: +81 359775001p:+81 359775001 BUNKYO-KU, TKY  113-8650  Japan Ticker: 45214521
Business Summary
KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment involves in the manufacture and sale of pharmaceuticals, medical devices and agricultural drugs. The Real Estate segment is engaged in the leasing of real estate.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2879 Pesticides and agricultural chemicals, not elsewhere classified
6512 Operators of nonresidential buildings
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Representative Director HiroyukiHoriuchi 60 6/1/2021 6/1/2016
Executive Officer, Chief Director of Sales TomoyukiKoseki 7/1/2023 7/1/2023
Executive Officer, Deputy Chief Director of Research and Development, Manager of New Drug Discovery TatsuhiroHarada 7/1/2023 7/1/2023
8 additional Officers and Directors records available in full report.

Business Names
Business Name
4521
Kaken Pharmaceutical Co., Ltd.

General Information
Number of Employees: 1,130 (As of 3/31/2023)
Outstanding Shares: 37,869,888 (As of 12/31/2023)
Shareholders: 10,783
Stock Exchange: TYO
Fax Number: +81 359775131


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 15, 2024